News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Myeloma Paper of the Day, February 4th, suggested by Robert Orlowski
Feb 4, 2025, 14:21

Myeloma Paper of the Day, February 4th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Study of the efficacy of isatuximab, pomalidomide, and dexamethasone in patients with multiple myeloma  refractory to daratumumab finds median PFS of 5.8 months (12-month PFS 30.6%); Hb <11.8 g/L predicted 3.5x increased risk of progression, high risk FISH was 10x.”

Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study

Authors: Enrica Antonia Martino et al.

Myeloma Paper of the Day, February 4th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

cancer dexamethasone Enrica Antonia Martino Isatuximab MD Anderson Cancer Center Myeloma Paper of the Day OncoDaily Oncology Pomalidomide Robert Orlowski
Special Coverage
Blog
Apr 13, 2025, 17:15
Applications are open for the M2ICOS project - European School of Oncology
Stories
Apr 13, 2025, 17:11
From Resident to Survivor: Dr. Jessica Firdman Moore’s cancer journey at Sylvester Comprehensive Cancer Center
Blog
Apr 13, 2025, 17:05
Aruni Ghose: OncoFlow to evaluate AI models across the cancer continuum for clinical adoption
Blog
Apr 13, 2025, 16:53
Heitham Hassoun: All great hospitals are so much more than places to heal
Blog
Apr 13, 2025, 16:28
Rasha Aboelhassan: A fruitful International Society of Clinical Oncology meeting on breast cancer
Blog
Apr 13, 2025, 16:17
The Bulgarian government has adopted an expanded national vaccination programme for HPV - European Cancer Organisation
Blog
Apr 13, 2025, 16:17
Chinmay Jani: SCLC no longer left behind
Blog
Apr 13, 2025, 16:12
Dr. Ira Mellman Joins the Parker Institute as President of Research
Blog
Apr 13, 2025, 16:10
World Health Worker Week: Celebrating the Unsung Heroes of Our Health Systems
Insight
Apr 13, 2025, 16:08
iwCAR-T 2025 Highlights – Unleashing the Next Frontier in Immunotherapy
Blog
Apr 13, 2025, 16:03
Debra Montague Becomes New President of Lung Cancer Europe: A Big Win for Patient Advocacy
Blog
Apr 13, 2025, 15:47
Misty Dawn Shields: Outstanding faculty discussions on lung cancer at Texas Lung Cancer Conference 2025